Literature DB >> 26009747

Another good reason to recommend low-dose aspirin.

Sonia Oyola1, Katherine Kirley1.   

Abstract

Evidence shows that daily low-dose aspirin during pregnancy can safely lower the risk of preeclampsia and other adverse outcomes.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26009747      PMCID： PMC4443891     

Source DB:  PubMed          Journal:  J Fam Pract        ISSN： 0094-3509            Impact factor:   0.493


  8 in total

1.  Maternal mortality from preeclampsia/eclampsia.

Authors:  Labib Ghulmiyyah; Baha Sibai
Journal:  Semin Perinatol       Date:  2012-02       Impact factor: 3.300

Review 2.  Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies.

Authors:  Kirsten Duckitt; Deborah Harrington
Journal:  BMJ       Date:  2005-03-02

3.  Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy.

Authors: 
Journal:  Obstet Gynecol       Date:  2013-11       Impact factor: 7.661

4.  Low-dose aspirin use for the prevention of morbidity and mortality from preeclampsia: U.S. Preventive Services Task Force recommendation statement.

Authors:  Michael L LeFevre
Journal:  Ann Intern Med       Date:  2014-12-02       Impact factor: 25.391

Review 5.  Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force.

Authors:  Jillian T Henderson; Evelyn P Whitlock; Elizabeth O'Connor; Caitlyn A Senger; Jamie H Thompson; Maya G Rowland
Journal:  Ann Intern Med       Date:  2014-05-20       Impact factor: 25.391

6.  Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis.

Authors:  Cande V Ananth; Katherine M Keyes; Ronald J Wapner
Journal:  BMJ       Date:  2013-11-07

Review 7.  Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data.

Authors:  Lisa M Askie; Lelia Duley; David J Henderson-Smart; Lesley A Stewart
Journal:  Lancet       Date:  2007-05-26       Impact factor: 79.321

Review 8.  Antiplatelet agents for preventing pre-eclampsia and its complications.

Authors:  L Duley; D J Henderson-Smart; S Meher; J F King
Journal:  Cochrane Database Syst Rev       Date:  2007-04-18
  8 in total
  1 in total

Review 1.  Molecular Targets of Aspirin and Prevention of Preeclampsia and Their Potential Association with Circulating Extracellular Vesicles during Pregnancy.

Authors:  Suchismita Dutta; Sathish Kumar; Jon Hyett; Carlos Salomon
Journal:  Int J Mol Sci       Date:  2019-09-05       Impact factor: 5.923
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.